- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06788951
The Effect of Oral Carbohydrate Inhalation Given to Patients Before Coronary Artery Bypass Graft Operation on Recovery
Investigation of the Effects of Oral Carbohydrate Solution Given to Patients Before Coronary Artery Bypass Graft Surgery on Postoperative Nausea and Vomiting, Feeling of Hunger and Thirst, Physiological Parameters and Recovery
The aim of this study was to investigate the effect of oral carbohydrate solution given to patients before coronary artery bypass graft surgery on nausea-vomiting, hunger, thirst, physiologic parameters and recovery.
The study will be completed with a total of 120 participants, 40 control, 40 placebo and 40 experimental.
As a randomization method, simple randomization method will be used to provide an equal number of samples in three groups and patients will be informed verbally about the study and written informed consent will be obtained from patients who agree.
In this study, the effects of oral carbohydrate solution administration on nausea and vomiting, hunger, thirst, physiologic parameters and recovery were evaluated before coronary artery bypass graft surgery.
Study Overview
Status
Conditions
Detailed Description
Experimental: Oral administration of carbohydrate solution Patients will receive 800 ml of oral carbohydrate solution until midnight before surgery and 400 ml until 2 hours before surgery. Patients will be administered a Patient Information Form before surgery. Postoperative Recovery Index (Turkish Version), Visual Comparison Scale, Physiologic Parameters and Blood Glucose Monitoring Form and Number and Dosage of Antiemetic Drugs Taken in 24 Hours Postoperatively will be applied.
Placebo: Administration of flavored water Patients will be given 800 ml of flavored water until midnight before surgery and 400 ml of flavored water until 2 hours before surgery. Patients will be given a Patient Information Form before surgery. Postoperative Recovery Index (Turkish Version), Visual Comparison Scale, Physiologic Parameters and Blood Glucose Monitoring Form and Number and Dosage of Antiemetic Drugs Taken in 24 Hours Postoperatively will be applied.
Control: No intervention Patients will be administered a Patient Information Form before surgery. Postoperative Recovery Index (Turkish Version), Visual Comparison Scale, Physiologic Parameters and Blood Glucose Monitoring Form and Number and Dosage of Antiemetic Drugs Taken in 24 Hours Postoperatively will be applied.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tuşba
-
VAN, Tuşba, Turkey, 065
- Yasemin BOZKURT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- Planned coronary artery bypass graft surgery
- Volunteering to participate in the research
Exclusion Criteria:
- Under 18 years of age
- Not planned coronary artery bypass graft surgery
- Not volunteering to participate in the research
- Cases received as an emergency
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Oral carbohydrate solution was administered preoperatively
The experimental group will be given 800 ml of ora carbohydrate solution until midnight before surgery and 400 ml 2 hours before surgery.
Patient Information Form will be collected from the patients before surgery.
After the surgery, the Visual Comparison Scale, Physiological Parameters and Blood Glucose Monitoring, Form Postoperative Recovery Index (Turkish Version), and the Number and Dosage of Antiemetic Drugs Taken in the Postoperative 24 Hours form will be used.
|
Oral carbohydrate solution will be administered to patients before coronary artery bypass graft operation and its effects on postoperative nausea-vomiting, hunger, thirst, physiological parameters and recovery will be evaluated.
|
|
Placebo Comparator: Flavored Water Applied Before Surgery
The placebo group will receive 800 ml of flavored water until midnight before surgery and 400 ml 2 hours before surgery.
A Patient Information Form will be collected from the patients before surgery.
After the surgery, the Visual Comparison Scale, Physiological Parameters and Blood Glucose Monitoring Form, Postoperative Recovery Index (Turkish Version) and the Number and Dosage of Antiemetic Drugs Taken in 24 Hours Postoperatively will be used.
|
The effects of flavored water given to patients before coronary artery bypass graft operation on postoperative nausea-vomiting, hunger and thirst,
|
|
No Intervention: No Preoperative Intervention
No intervention will be made to patients who will undergo surgery.
Patient Information Form will be collected from the patients before surgery.
After the surgery, the Visual Comparison Scale, Physiological Parameters and Blood Glucose Monitoring Form, Postoperative Recovery Index (Turkish Version) and the Number and Dosage of Antiemetic Drugs Taken in 24 Hours Postoperatively will be used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Information Form
Time Frame: Up to 24 weeks
|
The personal information form used in the data collection process consists of demographic characteristics of the individuals such as age, gender, marital status, occupation, educational status and employment status, as well as health-related conditions of the patients such as chronic diseases and past surgical history.
|
Up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Recovery Index (Turkish Version)
Time Frame: Up to 24 weeks
|
The Postoperative Recovery Index (PRAI) used in the validity and reliability study conducted by Butler et al. (2012) consists of 25 items.
This index includes psychological symptoms, physical activities, general symptoms, bowel symptoms and craving symptoms.
In scoring the questionnaire, the scores of the items in each subscale are summed and a subscale score is obtained by taking the arithmetic mean.
The ASI overall questionnaire score is calculated by taking the arithmetic mean of the total score over 25 items.
Higher scores on the index indicate that postoperative recovery is more difficult and lower scores indicate that recovery is easier.
The minimum score value in each parameter of this scale is 0 and the maximum score value is 5.
In this study, the Cronbach's alpha coefficient of the ASIQ was 0.97, 0.90 for the psychological symptoms subscale, 0.83 for the physical activity subscale and 0.98 for the discomfort subscale.
|
Up to 24 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number and Dosage of Antiemetic Drugs Taken in 24 Hours Postoperatively
Time Frame: Up to 24 weeks
|
This questionnaire was used to assess the dose and number of antiemetic drugs used in the postoperative period.
This questionnaire was used to measure patients' nausea and vomiting in the postoperative period.
Scoring was evaluated on a scale of 0-10.
The closer the score range was to 10, the higher the discomfort rate of the patients, while a score range closer to 0 indicated less discomfort.
|
Up to 24 weeks
|
|
Physiological Parameters and Blood Glucose Monitoring Form
Time Frame: Up to 24 weeks
|
This form is a comprehensive tracking tool for monitoring patients' vital signs.
It includes regular recording of important parameters such as blood pressure, pulse rate, respiratory rate, oxygen saturation, body temperature and blood sugar.
These regular measurements allow monitoring changes in the surgical process and the recovery process.
The optimal value range of blood pressure is 120/80 mg/dl, pulse rate range is between 60-100 per minute, respiratory rate optimal value is between 12-20 per second, oxygen saturation optimal value is between 95-100, body temperature value is between 36-37'C, and blood glucose value is close to 90-140 values are close to the optimal value and the effect of oral carbohydrate solution on postoperative physiological parameters is positive.
|
Up to 24 weeks
|
|
Visual Benchmark Scale
Time Frame: Up to 24 weeks
|
This scale is used to measure various parameters such as hunger, thirst, nausea and vomiting.
The scale value ranges from 0 to 10, with an increase in value indicating an increase in the relevant parameters.
The minimum score on this scale is 0 and the maximum score is 10.
|
Up to 24 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Ybozkurt
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
MedtronicCompletedThoracic Surgery | Spine Surgery | Upper Extremity Surgery | Lower Extremity Surgery | Intracranial Surgery | Extracranial Surgery | Intratemporal Surgery | Extratemporal Surgery | Neck SurgeryGermany
-
[Redacted]3M; Solventum US LLCWithheldAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Maquet Cardiopulmonary GmbHNAMSATerminatedCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain, Italy
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingAnesthesia, Local | Foot Surgery | Hand Surgery | Walant SurgeryFrance
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
Clinical Trials on administration of oral carbohydrate solution to patients before coronary artery bypass graft surgery
-
Tamer cebeIstanbul University - Cerrahpasa (IUC)CompletedInvestigation of Myocardial Protection Efficacy of Cardioplegia Solutions Used in Open Heart SurgeryCardiovascular Diseases | Myocardial Reperfusion InjuryTurkey
-
Boston Scientific CorporationCardialysis BVUnknownCoronary Artery DiseaseUnited States, Italy, Latvia, Netherlands, United Kingdom, France, Spain, Sweden, Germany, Hungary, Poland, Portugal, Austria, Belgium, Norway, Czech Republic, Denmark, Finland
-
Seung-Jung ParkAbbott Medical Devices; CardioVascular Research Foundation, KoreaTerminatedCoronary Artery DiseaseThailand, Korea, Republic of, China, Malaysia
-
Ferring PharmaceuticalsTerminatedCrohn´s DiseaseUnited Kingdom, United States, Germany, Belgium, Denmark, France, Sweden
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...CompletedSurgery | Hepatic Impairment | Cardiac Disease | Hyperbilirubinemia
-
CHU de ReimsUnknownPatients Ongoing Elective Abdominal LaparoscopyFrance
-
Mohit KheraTerminatedErectile Dysfunction | HypogonadismUnited States